Dongwha Pharm Co.,Ltd. is engaged in manufacturing and distribution of medicines and pharmaceutical products including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies. The company also offers OTC drugs such as cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. Dongwha Pharm Co.,Ltd. developed a radiopharmaceutical drug for liver cancer known as Milican Injection. The company is based in Seoul, South Korea. Dongwha Pharm Co.,Ltd. was incorporated in 1970.
Headquarters
5 Sunhwa-Dong, Jung-Gu
Seoul; Seoul;
Postal Code: 100-130
Contact Details: Purchase the Dongwha Pharm Co.,Ltd. report to view the information.
Website: http://www.dong-wha.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service